The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
List view / Grid view
American Cancer Society
Filter the results
The advent of immune checkpoint inhibitors is a major breakthrough in cancer immunotherapy...
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Ligands are useful tools for studying how proteins work in cells and could lead to the development of new drugs.